Aceragen Inc
ACGN
ACGN was delisted on the 21st of August, 2023.
67 hedge funds and large institutions have $93.9M invested in Aceragen Inc in 2014 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 8 closing their positions.
350% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 8
68% more funds holding
Funds holding: 40 → 67 (+27)
0% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 12
12% less capital invested
Capital invested by funds: $107M → $93.9M (-$13M)
35% less call options, than puts
Call options by funds: $2.87M | Put options by funds: $4.41M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.8M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.85M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.61M |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$2.65M |
| 5 |
WSA
Wall Street Associates
Lajolla,
California
|
+$2.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$15.5M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$7.85M |
| 3 |
Millennium Management
New York
|
-$3.81M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$2.55M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$2.51M |
ACGN Hedge Fund Activity: Q1 2014 in Review
67 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Aceragen Inc (ACGN) for Q1 2014, worth a combined $93.9M — down 12% from $107M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new ACGN positions and 8 closed out — a net gain of 28 holders — while 12 added to existing stakes and 12 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $14.8M. The largest seller was HealthCor Management, exiting entirely with an estimated $15.5M sold.
- 67 institutional investors held Aceragen Inc (ACGN) as of Q1 2014, up from 40 in Q4 2013.
- Funds reported $93.9M of Aceragen Inc stock for Q1 2014, down 12% quarter-over-quarter.
- 36 funds opened new Aceragen Inc positions in Q1 2014 and 8 closed out, a net change of +28 holders.
- The largest Aceragen Inc buyer in Q1 2014 was Fidelity Investments, an estimated $14.8M added.
- The largest Aceragen Inc seller in Q1 2014 was HealthCor Management, an estimated $15.5M sold.
Based on aggregated 13F filings for Q1 2014.